Mr. Anttila has been in the quality profession for 60 years, incl. 35 years at Telecom Finland, e.g. as Vice President Quality Integra)on. He has been active in international standardization (e.g. ISO TC 176). He was Vice President of EOQ 1994-96, and Academician of IAQ since 1995. He is Honorary Member of the Finnish Society for Quality and the Croatian Quality Managers Society. He was one of the founders of the Finnish Quality Award and an assessor of the European Quality Award. Now he is acting as an independent researcher.

The Study on quality management problems related to Covid-19 pandemic:

The quality of Covid-19 vaccines cannot be considered acceptable. QA and QM were not implemented properly or did not have the necessary impact. Risk management has not been applied, and there were ethically questionable aspects to responsible operations. All this has led to serious health, economic and social problems, which are problems of the quality of society. A revival of quality practices and major changes are necessary throughout the pharmaceutical and healthcare ecosystem.